Bond Teva Pharmaceutical Finance Netherlands III B.V 8.125% ( US88167AAR23 ) in USD
Issuer | Teva Pharmaceutical Finance Netherlands III B.V |
Market price | ![]() |
Country | ![]() |
ISIN code |
![]() |
Interest rate | 8.125% per year ( payment 2 times a year) |
Maturity | 14/09/2031 |
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
Minimal amount | 200 000 USD |
Total amount | 500 000 000 USD |
Cusip | 88167AAR2 |
Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) |
Moody's rating | Ba2 ( Non-investment grade speculative ) |
Next Coupon | 15/09/2025 ( In 149 days ) |
Detailed description |
Teva Pharmaceutical Finance Netherlands III B.V. is a subsidiary of Teva Pharmaceutical Industries Ltd., a global pharmaceutical company, and functions as a financing vehicle within its broader corporate structure. The Bond issued by Teva Pharmaceutical Finance Netherlands III B.V ( Israel ) , in USD, with the ISIN code US88167AAR23, pays a coupon of 8.125% per year. The coupons are paid 2 times per year and the Bond maturity is 14/09/2031 The Bond issued by Teva Pharmaceutical Finance Netherlands III B.V ( Israel ) , in USD, with the ISIN code US88167AAR23, was rated Ba2 ( Non-investment grade speculative ) by Moody's credit rating agency. The Bond issued by Teva Pharmaceutical Finance Netherlands III B.V ( Israel ) , in USD, with the ISIN code US88167AAR23, was rated BB ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |